GOLDMAN SACHS GROUP INC - ATOSSA THERAPEUTICS INC ownership

ATOSSA THERAPEUTICS INC's ticker is ATOS and the CUSIP is 04962H506. A total of 58 filers reported holding ATOSSA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of ATOSSA THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$70,000
-45.3%
64,273
-37.2%
0.00%
Q1 2022$128,000
-69.2%
102,321
-60.6%
0.00%
Q4 2021$416,000
-38.5%
259,856
+25.2%
0.00%
Q3 2021$676,000
+113.9%
207,569
+315.1%
0.00%
Q2 2021$316,000
+134.1%
50,007
-21.6%
0.00%
Q1 2021$135,000
+159.6%
63,770
+199.3%
0.00%
Q3 2020$52,00021,3040.00%
Other shareholders
ATOSSA THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 524,805$572,0000.39%
Laurion Capital Management LP 2,225,800$2,426,0000.04%
Ergoteles LLC 514,600$561,0000.02%
Pinz Capital Management, LP 17,900$20,0000.01%
Alpine Global Management, LLC 37,089$40,0000.01%
Game Plan Financial Advisors, LLC 10,000$11,0000.01%
Spire Wealth Management 100,300$109,0000.00%
Renaissance Technologies 1,989,995$2,169,0000.00%
D. E. Shaw & Co., Inc. 2,279,636$2,485,0000.00%
Y-Intercept (Hong Kong) Ltd 16,912$18,0000.00%
View complete list of ATOSSA THERAPEUTICS INC shareholders